Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Esophageal Neoplasms × atezolizumab × Clear all

Phase

Phase 2 3 Phase 1/2 2 Phase 1 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 18 Carcinoma, Hepatocellular 12 Small Cell Lung Carcinoma 9 Triple Negative Breast Neoplasms 7 Neoplasms 7 Breast Neoplasms 6 Urinary Bladder Neoplasms 4 Ovarian Neoplasms 4 Lung Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Transitional Cell 3 Melanoma 2 Colonic Neoplasms 2 Carcinoma 2 Venous Thrombosis 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Non-Small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases 1 Rectal Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1 Non-Squamous Non-Small Cell Lung Cancer 1 Non-Small-Cell Lung 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms by Site 1

Interventions

Cisplatin 28 Fluorouracil 21 Paclitaxel 19 Radiotherapy 16 Docetaxel 10 Radiation 7 Esophagectomy 7 Neoadjuvant Therapy 6 Irinotecan 6 Carboplatin 6 Oxaliplatin 5 Leucovorin 5 Capecitabine 5 sintilimab 4 pembrolizumab 4 camrelizumab 4 TP protocol 4 Surgical Procedures, Operative 4 Drug Therapy 4 Chemotherapy, Adjuvant 4 Trastuzumab 3 Immunotherapy 3 Chemoradiotherapy 3 tislelizumab 2 nimotuzumab 2 S 1 (combination) 2 Radiotherapy, Adjuvant 2 Platinum Compounds 2 Nivolumab 2 Immune Checkpoint Inhibitors 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04540211 2025-10-28

SKYSCRAPER-08

Hoffmann-La Roche

Phase 3 Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡